The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

The government agency says X no longer suits its communication needs.

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

EUR/USD declines to near 1.0370 as inflation in six states of Germany decelerates in January.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...

The EUR/JPY cross gains momentum to around 160.75, snapping the two-day losing streak during the early European session on ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

As users continue to leave X (formerly Twitter) en masse, many in favor of the newer Bluesky platform, the European Medicines ...

The European Medicines Agency (EMA), which is the regulator for vaccines and medicine in the European Union (EU), has stopped ...

Paracetamol, now comes with a shocking new warning: it could lead to a dangerous condition called metabolic acidosis if ...

EUR/USD struggles as ECB holds rates at 2.90%, while weak German data fuels growth concerns. Will the euro rebound or slide ...